Slovak shot-putter Milan Haborák tested positive in a B-sample analysis for the banned substance stanozolol, the Slovak Anti-Doping Agency (ADA) announced on Wednesday, July 21. As this is Haborák’s second doping offence, he will probably receive a lifetime ban.
“By today’s laboratory announcement it was confirmed that the B-sample was also positive for stanozolol metabolites. The B-sample has therefore confirmed the A-sample analysis,” said ADA director Miroslav Motyčík, adding that the agency has notified both the athlete and the Slovak Track and Field Association (SAZ), which will therefore be able to launch disciplinary proceedings.
The ADA reported last week that an unnamed athlete had tested positive for stanozolol. As all the evidence pointed to Haborák, the SAZ temporarily suspended him. Haborák came under suspicion when he pulled out of the upcoming European Championships in Barcelona, citing a fatigue fracture of a bone in his left foot. He was subsequently tested by Slovak anti-doping officers at his home on June 21. Haborák, 37, also tested positive at a meeting in Madrid in July 2004, after which he was banned for two years.
Source: TASR
Compiled by Zuzana Vilikovská from press reports
The Slovak Spectator cannot vouch for the accuracy of the information presented in its Flash News postings.
